ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Coronavirus trials for Actemra arthritis drug to start in Japan

Chugai and Roche's medication already set for tests in US

The trials will determine whether the arthritis treatment is effective against pneumonia caused by coronavirus infection.   © Reuters

TOKYO -- Chugai Pharmaceutical will conduct a clinical trial in Japan using its Actemra arthritis medication to treat patients with coronavirus-induced pneumonia.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more